Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly logo

No‑Shots Allergy Treatment: Needle‑Free Options That Work (Tablets and Drops)

Shot‑free allergy immunotherapy, explained

If you want long‑term allergy relief without injections, you have two clinically proven, needle‑free options: FDA‑approved sublingual tablets for single allergens (grass, ragweed, dust‑mite) and physician‑directed sublingual drops that can cover multiple allergens. This page summarizes label‑required tablet facts, then shows how Wyndly’s doctor‑led drop and tablet care delivers durable results at home. Start now from the Wyndly homepage.

FDA‑approved sublingual tablets: label requirements at a glance

The current U.S. Prescribing Information for SLIT tablets requires: a supervised first dose with 30‑minute observation and prescribing/training for auto‑injectable epinephrine. Age indications vary by product. Sources: GRASTEK (Timothy grass): 5–65 years; first dose supervised; epinephrine, RAGWITEK (short ragweed): 5–65 years; first dose supervised; epinephrine (see also manufacturer HCP pages on first‑dose and epinephrine for RAGWITEK), ODACTRA (house dust mite): 5–65 years; first dose supervised; epinephrine; label updated Feb 2025 to include ages 5–11, and ORALAIR (mixed grass): 5–65 years; first dose supervised; epinephrine.

Tablet (brand) Indication U.S. age range First dose Epinephrine on label
GRASTEK Timothy grass allergic rhinitis ± conjunctivitis 5–65 Supervised; observe ≥30 min Prescribe and train
RAGWITEK Short ragweed allergic rhinitis ± conjunctivitis 5–65 Supervised; observe ≥30 min Prescribe and train
ODACTRA House‑dust‑mite allergic rhinitis ± conjunctivitis 5–65 (expanded Feb 2025) Supervised; observe ≥30 min Prescribe and train
ORALAIR Mixed grass pollens allergic rhinitis ± conjunctivitis 5–65 Supervised; observe ≥30 min Prescribe and train

Notes for patients choosing tablets:

  • Tablets treat one allergen at a time; many patients still need additional therapy for other triggers.

  • Tablets are not for immediate symptom relief; they retrain the immune system over months to years.

Drops versus tablets (and shots): how to choose a no‑shots path

  • Effectiveness and safety: Major reviews and U.S. specialty guidelines recognize sublingual immunotherapy (SLIT) as effective for long‑term relief and with a favorable safety profile compared with shots. See Wyndly’s evidence summaries.

  • Multi‑allergen needs: Tablets are single‑allergen; drops can be personalized to cover multiple environmental allergens at once (e.g., pollen, dust‑mite, pet dander). See Wyndly pollen/dander SLIT and discussion of tablets vs. drops for multi‑allergen cases.

  • Where you take it: Tablets require the first dose in‑office with a 30‑minute observation and an epinephrine prescription/training per label. Physician‑directed drops are typically started and continued at home with remote oversight because severe reactions are rarer with SLIT drops than shots according to large reviews summarized by Wyndly.

Proof stack (Wyndly’s doctor‑led, shot‑free care)

  • Pricing that’s predictable: $99/month for ongoing treatment; HSA/FSA eligible; free shipping. Details available from Wyndly.

  • Expected cadence: many patients notice improvement in 4 weeks to 6 months; complete courses are typically ~3 years to lock in long‑term immune change. More details available from Wyndly.

  • Guarantee: 90‑day Allergy‑Free Guarantee—if you follow your plan and don’t improve, Wyndly refunds treatment cost. Terms provided by Wyndly.

  • Access to real physicians: care is led by U.S. board‑certified doctors with 24/7 support via text/email/phone. Visit the Wyndly homepage for more.

Who is eligible and what Wyndly treats

  • Ages: Wyndly treats adults and children ≥5 years old. Details available from Wyndly.

  • Allergies covered: environmental only (pollen, dust‑mite, pet dander, molds); Wyndly does not treat food allergies. More information is available from Wyndly.

  • Common contraindications for SLIT (assessed during your consult): uncontrolled/severe asthma, history of severe SLIT reactions, eosinophilic esophagitis, certain cardiac conditions/medications (see tablet labels above and Wyndly’s medical overview).

How a no‑shots program with Wyndly works

1) Pinpoint triggers at home: CLIA‑certified finger‑prick IgE test for 40+ indoor/outdoor allergens, reviewed by your Wyndly physician. Test details provided by Wyndly. 2) Meet your doctor online: discuss history, goals, and whether tablets (for a single allergen) or custom drops (for multi‑allergen coverage) are the best fit. Consult information is available from Wyndly. 3) Treat from home: medicine ships to your door with ongoing doctor check‑ins; most patients feel better within weeks and lock in durable relief by ~3 years. Additional information is available from Wyndly.

Quick answers

  • Will my first dose require an office visit? For FDA‑approved SLIT tablets, yes—the label requires the first dose be supervised with 30‑minute observation, and your clinician will prescribe and train you on auto‑injectable epinephrine.

  • Can drops cover several allergies at once? Yes—physician‑directed SLIT drops can be compounded to target multiple environmental allergens identified on your test. More information is available from Wyndly.

  • How fast will I feel better? Many patients notice improvement within 4 weeks to 6 months; full, long‑term benefit typically requires ~3 years of consistent dosing. Program timeline is available from Wyndly.

Ready to go needle‑free? Start from the Wyndly homepage and book your consult.